A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster
Status:
Not yet recruiting
Trial end date:
2023-07-30
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy, optimal dose and efficacy trend of multiple subcutaneous injections
of peginterferon α1b in patients with herpes zoster, and provide support for phase III
clinical trials.
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai Institute Of Biological Products
Collaborator:
Chinese Academy of Medical Sciences Dermatology Hospital